Vaxxinity, Inc. (VAXX)
OTCMKTS: VAXX · Delayed Price · USD
0.275
-0.025 (-8.37%)
Jul 2, 2024, 3:46 PM EDT - Market closed
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $34.85 million as of July 2, 2024. Its market cap has decreased by -86.96% in one year.
Market Cap
34.85M
Enterprise Value
19.52M
1-Year Change
-86.96%
Ranking
n/a
Category
Stock Price
$0.27
Market Cap Chart
Since the IPO on November 11, 2021, Vaxxinity's market cap has decreased from $1.45B to $34.85M, a decrease of -97.60%. That is a compound annual growth rate of -77.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 8, 2024 | 14.10M | -86.91% |
Dec 29, 2023 | 107.70M | -38.98% |
Dec 30, 2022 | 176.50M | -74.91% |
Dec 31, 2021 | 703.50M | -51.50% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 869.02B |
Novo Nordisk | 643.34B |
UnitedHealth Group | 455.27B |
Johnson & Johnson | 352.43B |
Merck & Co. | 323.95B |
AbbVie | 300.85B |
AstraZeneca | 241.65B |
Novartis AG | 208.44B |